Provided by Tiger Trade Technology Pte. Ltd.

Vor Biopharma Inc.

24.73
+2.099.23%
Volume:591.62K
Turnover:14.27M
Market Cap:1.46B
PE:2.15
High:24.84
Open:22.67
Low:22.67
Close:22.64
52wk High:49.95
52wk Low:6.50
Shares:59.16M
Float Shares:37.23M
Volume Ratio:1.04
T/O Rate:1.59%
Dividend:- -
Dividend Rate:- -
EPS(TTM):11.53
EPS(LYR):-70.5015
ROE:-125.43%
ROA:-21.37%
PB:-7.31
PE(LYR):-0.35

Loading ...

Mar 23, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 16, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 23, 2022

Major Issues Report

8-K - Current report
Dec 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Dec 14, 2022

Major Issues Report

8-K - Current report
Dec 09, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 07, 2022

Major Issues Report

8-K - Current report
Dec 07, 2022

Major Issues Report

8-K - Current report
Nov 29, 2022

Major Issues Report

8-K - Current report
Nov 14, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 10, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 27, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Aug 11, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2022

Major Issues Report

8-K - Current report
May 12, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 14, 2022

Major Issues Report

8-K - Current report
Mar 16, 2022

Correspondence

CORRESP [Cover] - Correspondence
Mar 14, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans